Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
The power of compounding in finance can transform your savings and investments. Learn how it unlocks significant growth potential over time.
17,134 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Accredited investors can now access a portfolio of 25,000+ multifamily units via Lightstone's private-market platform...
Tuesday brought a notable wobble for the Nasdaq-100, leading the market’s tech retreat. This article breaks down the ...
Rapid shifts in freight markets are driving the SonicShares Global Shipping ETF's payouts. Here are the two rates boa...
An AI investment story built on Nvidia backing and a defense tech tie-up is gaining attention. This article breaks do...
A senior strategist at a massive $1.8 trillion fund warns that long-dated Treasuries are unlikely to shield retiremen...
As market volatility persists in 2026, retirees with a $100K variable annuity inside an IRA confront a key choice: ta...
A niche copper miners ETF has surged more than 150% over the past year as AI data center growth boosts copper demand....
A fresh take on LUCD's early 2026 results, this analysis dives into the lucd 2026 earnings transcript to unpack reven...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...